Compounded Sterile Preparations Pharmacy

Compounded Sterile Preparations Pharmacy ensures that sterile preparations meet the clinical needs of patients, satisfying quality, safety, and environmental control requirements in all phases of preparation, storage, transportation, and administration in compliance with established standards, regulations, and professional best practices. Currently there are more than 400 BPS Board Certified Sterile Compounding Pharmacists.

NOTE: The BPS content outline for the examination in Compounded Sterile Preparations Pharmacy refers to “knowledge of standards related to sterile preparation (e.g., United States Pharmacopeia…)”. [Domain 1, Task 2].

 

All BPS specialty certification examinations reflect current, best practices, at the time they are constructed – practice guidelines used for the Spring examination are those that are current as of January 1 of the testing year. Practice guidelines for the Fall examination are those that are current as of July 1 of the testing year.

 

USP released new versions of Chapters <795> Pharmaceutical Compounding – Nonsterile Compounding and <797> Pharmaceutical Compounding – Sterile Preparations on June 1, 2019 and they were scheduled to become effective December 1, 2019.  USP Chapter <800> Hazardous Drugs – Handling in Healthcare Settings is a new chapter published by USP in 2016 and originally scheduled to become official in December 2017. USP decided to delay the date of official implementation until December 1, 2019 in order to align the official implementation date of Chapter <800> with the implementation dates of these two other related chapters.

 

The scheduled implementation of compounding chapters <795> and <797> has been indefinitely postponed by USP pending an appeal related to concerns about issues related to certain content in some of the chapters. A hearing on the appeal is scheduled for January 20-21, 2020. Once a decision is made on the appeal, USP will announce next steps and a timeline for implementation.  If the appeal is denied, a minimum of six months will be provided to allow for implementation of the standards. If the appeal is upheld, a process will be announced for revision to address concerns related to the appeal, and a longer timeframe is expected.

 

The United States Pharmacopoeia has a Frequently Asked Questions document about the compounding appeal at this link: https://www.usp.org/sites/default/files/usp/document/our-work/compounding/faqs-on-compounding-appeals.pdf

 

Chapter <800> became official on December 1, 2019. During the postponement and pending the resolution of the appeals of chapters <795> and <797>, however, chapter <800> is considered informational by USP and not compendially applicable.

 

Due to the postponement of USP chapter <797> beyond January 1 of 2020, the Spring 2020 Compounded Sterile Preparations examination will be based upon the 2008 version of USP chapter <797> rather than the newly revised version.

 

Please note that this information is offered by BPS to help reduce confusion regarding USP Chapters <797> and <800>, and that there are other standards and regulations that are applicable to the Compounding Sterile Preparations examination.

 

For the content outline for the BPS Compounded Sterile Preparations Pharmacy examination, click here.

 

For updates and timelines on the status of revisions to USP Chapters, check this USP web page: https://www.usp.org/compounding.

BPS Board Certification in Compounded Sterile Preparations Pharmacy program is a credential for pharmacists who have met the eligibility criteria and who in their unique practice are responsible for ensuring that sterile preparations meet the clinical needs of patients, satisfying quality, safety, and environmental control requirements in all phases of preparation, storage, transportation, and administration in compliance with established standards, regulations, and professional best practices.

The purpose of the BPS Board Certification in Compounded Sterile Preparations Pharmacy program is to validate a pharmacist’s advanced knowledge and experience to:

  • Ensure quality patient care;
  • Improve therapeutic outcomes;
  • Assure safety;
  • Supervise, train, and ensure competency of all personnel involved in sterile compounding.

Pharmacists who, meet all of the eligibility criteria including passing the examination will be awarded the credential titled: Board Certified Sterile Compounding Pharmacist (BCSCP).

Effective January 1, 2019: All applicants intending to demonstrate eligibility for any BPS certification examination utilizing the practice experience pathway must provide an attestation from their employer, on company letterhead, that verifies this experience accurately represents 50% of time spent in some or all of the activities defined by the applicable certification content outline. In addition, this practice experience must have occurred within the seven years immediately preceding the application. For more information, click here.

(All practice eligibility requirements must be met prior to the candidate sitting for the examination)

The minimum requirements for the Compounded Sterile Preparations Pharmacy specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • A current, active license/registration to practice pharmacy in the U.S. or another jurisdiction
  • 4,000 hours of post licensure/registration practice experience in compounded sterile preparations pharmacy*
  • Achieving a passing score on the Compounded Sterile Preparations Specialty Certification Examination

*The 4,000 hours of experience required may be earned in a variety of settings. ASHP-accredited residencies that include practice hours in the activities listed in the Compounded Sterile Preparations Content Outline will be accepted as practice experience on an hour-for-hour basis. As of 2019, all applicants will be required to provide an attestation for practice experience from their employer, and the required practice hours must be demonstrated during the seven years prior to the application date.

The rationale for the appropriateness of the requirements for BPS certification programs are based upon the following:

  • BPS recognizes individuals who graduate from a recognized school or college of pharmacy within the candidate’s jurisdiction. Those jurisdictions recognize and evaluate programs on the extent to which it accomplishes its stated goals and is consistent with the concept that pharmacy is a unique, personal service profession in the health science field. In the United States, the responsibility for recognizing schools and colleges of pharmacy falls to the Accreditation Council for Pharmacy Education (ACPE).
  • The rationale for requiring licensure or registration of pharmacists within their jurisdiction is based upon the fact that for public protection, all pharmacists must be licensed or registered. This is considered a baseline requirement to be a pharmacist specialist. In the United States, BPS recognizes the licensure process administered by the National Association of Boards of Pharmacy (NABP). The National Association of Boards of Pharmacy (NABP) aims to ensure the public’s health and safety through its pharmacist license transfer and pharmacist competence assessment programs. NABP’s member boards of pharmacy are grouped into eight districts that include all 50 United States, the District of Columbia, Guam, Puerto Rico, the Virgin Islands, Bahamas, and all 10 Canadian provinces.
  • The experiential component is required to help assure practical application of components of the specialty knowledge being certified. There are multiple pathways to meet the practice experience requirement.  
  • Passing the BPS pharmacy specialty examination helps assure knowledge consistent with the validated content outline for the BPS specialty.

The appropriateness of the BPS program requirements are consistent with the Council on Credentialing in Pharmacy’s Resource Paper titled: Scope of Contemporary Pharmacy Practice: Roles, Responsibilities, and Functions of Pharmacists and Pharmacy Technicians.

  • Domain 1: Standards, Regulations, and Best Practices (20% of examination)
  • Domain 2: Facilities, Equipment, and Environmental Control (20% of examination)
  • Domain 3: Compounded Sterile Preparations (25% of examination)
  • Domain 4: Patient Care (15% of examination)
  • Domain 5: Quality Management (20% of examination)

Pharmacists who earn the designation Board Certified Sterile Compounding Pharmacist® (BCSCP) will be required to maintain their certification over a seven year period by completing one of the following professional development activities:

  • Option One: Recertification Examination
    Achieving a passing score on the 100-item recertification examination (administered by BPS), based on the content outline for the Compounded Sterile Preparations Specialty in the final year of the certification cycle;

OR

  • Option Two: Continuing Education
    Earning 100 hours of continuing education credit provided by the professional development programs offered by the American Pharmacists Association (APhA) and/or the American Society of Health-Systems Pharmacists (ASHP). Compounding Sterile Preparations Pharmacy Preparatory Review and Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle.

For full details regarding recertification, please refer to the BPS Recertification Guide.

Board Certified Sterile Compounding Pharmacists® are also required to pay the BPS Annual Certification Maintenance fee of $125 each year for years one through six and a $400 recertification fee in year seven. Individuals with more than one BPS certification will only be assessed one BPS Annual Certification Maintenance Fee each year.

Download PDF Fact Sheet

Compounded Sterile Preparations Pharmacy ensures that sterile preparations meet the clinical needs of patients, satisfying quality, safety, and environmental control requirements in all phases of preparation, storage, transportation, and administration in compliance with established standards, regulations, and professional best practices. Currently there are more than 400 BPS Board Certified Sterile Compounding Pharmacists.

The BPS Board Certified Sterile Compounding Pharmacist (BCSCP)® has the advanced knowledge and experience to:

  • Ensure quality patient care
  • Improve therapeutic outcomes
  • Assure safety
  • Supervise, train, and ensure competency of all personnel involved in sterile compounding

To become a BPS Board Certified Sterile Compounding Pharmacist® (BCSCP), a pharmacist must:

  • Graduate from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in the jurisdiction
  • Maintain a current, active license to practice pharmacy in the U.S. or another jurisdiction
  • Complete 4,000 hours of post-licensure experience in compounded sterile preparations pharmacy practice*
  • Achieve a passing score on the Compounded Sterile Preparations Specialty Certification Examination

* The 4,000 hours of experience required may be earned in a variety of settings. ASHP- accredited residencies that include practice hours in the activities listed in the Compounded Sterile Preparations Content Outline will be accepted as practice experience on an hour-for-hour basis. All applicants will be required to provide an attestation for practice experience from their employer, and the required practice hours must be obtained during the seven years prior to the application date.

Recertification is required every seven years by completing one of the following professional development activities:

  • Achieving a passing score on the 100-item, multiple-choice objective recertification examination (administered by BPS), based on the content outline for the Compounded Sterile Preparations Pharmacy Specialty in their seventh year following initial certification; or
  • Earning 100 hours of continuing education credit provided by a BPS-approved professional development program provider.

Compounded Sterile Preparations Pharmacy Preparatory Review and Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle.

Becoming BPS board certified enables pharmacists to:

  • Provide more comprehensive and complex patient care
  • Be prepared to step into pharmacy’s evolving position on the multidisciplinary treatment team
  • Experience increased recognition by other healthcare professionals, employers, patients and insurers
  • Improve their standing in a competitive employment market

Board certification through the Board of Pharmacy Specialties® is the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels. Through the rigorous examination standards mandated by the Board of Pharmacy Specialties®, the BPS board certified pharmacist is uniquely trained and educated to meet the continually expanding expectations of other healthcare team members and the specialized needs of the patients they serve.